Sio Capital Management
Latest statistics and disclosures from Sio Capital Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are AVR, COR, MMS, ALLO, GMED, and represent 32.06% of Sio Capital Management's stock portfolio.
- Added to shares of these 10 stocks: ALLO (+$28M), GMED (+$24M), COR (+$21M), SLS (+$18M), IDYA (+$18M), CI (+$16M), VTRS (+$15M), REGN (+$11M), BMY (+$11M), MDT (+$11M).
- Started 17 new stock positions in ENVB, BMY, SLS, AORT, HELP, REGN, VTRS, TNGX, CI, NMTC. MDT, IDYA, HIMS, QTI, AVAH, GMED, ALLO.
- Reduced shares in these 10 stocks: ICLR (-$38M), DNTH (-$30M), CORT (-$27M), LIVN (-$27M), EMBC (-$16M), ABVX (-$15M), WAY (-$15M), ANIP (-$14M), HAE (-$12M), TFX (-$11M).
- Sold out of its positions in ABVX, BMRN, BOLD, CNC, CMPS, CNTX, CORT, QDEL, CRNX, IRON.
- Sio Capital Management was a net seller of stock by $-134M.
- Sio Capital Management has $604M in assets under management (AUM), dropping by -13.34%.
- Central Index Key (CIK): 0001482416
Tip: Access up to 7 years of quarterly data
Positions held by Sio Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Sio Capital Management
Sio Capital Management holds 59 positions in its portfolio as reported in the June 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Anteris Technologies Global (AVR) | 9.0 | $55M | +3% | 5.5M | 9.85 |
|
| AmerisourceBergen (COR) | 8.1 | $49M | +72% | 174k | 282.98 |
|
| Maximus (MMS) | 6.4 | $39M | -6% | 715k | 53.76 |
|
| Allogene Therapeutics (ALLO) | 4.6 | $28M | NEW | 13M | 2.08 |
|
| Globus Med Cl A (GMED) | 3.9 | $24M | NEW | 302k | 79.01 |
|
| GSK Sponsored Adr (GSK) | 3.8 | $23M | +13% | 437k | 52.42 |
|
| Tyra Biosciences (TYRA) | 3.7 | $22M | +14% | 695k | 31.94 |
|
| Waystar Holding Corp (WAY) | 3.1 | $19M | -43% | 926k | 20.53 |
|
| Sellas Life Sciences Group I Com New Put Option (SLS) | 3.0 | $18M | NEW | 1.2M | 14.76 |
|
| Ideaya Biosciences (IDYA) | 3.0 | $18M | NEW | 480k | 37.27 |
|
| Oruka Therapeutics (ORKA) | 2.8 | $17M | +33% | 177k | 95.17 |
|
| Cigna Corp (CI) | 2.6 | $16M | NEW | 58k | 275.68 |
|
| Sanofi Sa Sponsored Adr (SNY) | 2.6 | $16M | +51% | 364k | 42.66 |
|
| Icon Pub SHS (ICLR) | 2.5 | $15M | -71% | 88k | 173.71 |
|
| Viatris (VTRS) | 2.5 | $15M | NEW | 954k | 15.88 |
|
| Cross Country Healthcare (CCRN) | 2.4 | $15M | 1.1M | 13.21 |
|
|
| Rapport Therapeutics (RAPP) | 2.1 | $13M | -16% | 308k | 41.67 |
|
| Abbott Laboratories (ABT) | 1.9 | $12M | -31% | 129k | 90.74 |
|
| Celcuity (CELC) | 1.9 | $12M | -43% | 110k | 104.62 |
|
| Zimmer Holdings (ZBH) | 1.9 | $11M | +109% | 131k | 86.09 |
|
| Regeneron Pharmaceuticals (REGN) | 1.9 | $11M | NEW | 18k | 623.54 |
|
| Bristol Myers Squibb (BMY) | 1.8 | $11M | NEW | 194k | 57.62 |
|
| Medtronic SHS (MDT) | 1.8 | $11M | NEW | 143k | 78.23 |
|
| Vir Biotechnology (VIR) | 1.8 | $11M | -28% | 1.1M | 10.19 |
|
| Senseonics Hldgs (SENS) | 1.5 | $9.0M | +1275% | 1.6M | 5.68 |
|
| Eyepoint Com New (EYPT) | 1.5 | $8.9M | -13% | 623k | 14.30 |
|
| Cybin Com New (HELP) | 1.4 | $8.6M | NEW | 1.3M | 6.61 |
|
| Biosante Pharmaceuticals (ANIP) | 1.3 | $8.1M | -63% | 97k | 82.78 |
|
| Protara Therapeutics Com Stk (TARA) | 1.2 | $7.3M | -2% | 1.9M | 3.82 |
|
| Relmada Therapeutics (RLMD) | 1.1 | $6.9M | +3% | 1.0M | 6.92 |
|
| Tango Therapeutics (TNGX) | 1.1 | $6.5M | NEW | 209k | 31.26 |
|
| Aquestive Therapeutics (AQST) | 1.0 | $6.2M | -22% | 1.5M | 4.16 |
|
| Dianthus Therapeutics (DNTH) | 1.0 | $5.8M | -83% | 59k | 97.48 |
|
| Sionna Therapeutics (SION) | 0.9 | $5.6M | -56% | 128k | 43.99 |
|
| Ocular Therapeutix (OCUL) | 0.9 | $5.3M | -44% | 540k | 9.82 |
|
| Zenas Biopharma (ZBIO) | 0.9 | $5.3M | -37% | 209k | 25.38 |
|
| Bright Minds Biosciences Com New (DRUG) | 0.9 | $5.2M | -14% | 74k | 70.20 |
|
| Onkure Therapeutics Com Cl A (OKUR) | 0.8 | $4.9M | 1.1M | 4.56 |
|
|
| Savara (SVRA) | 0.6 | $3.8M | 618k | 6.16 |
|
|
| Pmv Pharmaceuticals (PMVP) | 0.6 | $3.5M | -14% | 2.6M | 1.34 |
|
| Aveanna Healthcare Hldgs (AVAH) | 0.5 | $3.2M | NEW | 369k | 8.57 |
|
| Ovid Therapeutics (OVID) | 0.4 | $2.7M | -19% | 1.0M | 2.69 |
|
| Immunome (IMNM) | 0.4 | $2.6M | -24% | 124k | 21.19 |
|
| Hims & Hers Health Com Cl A Call Option (HIMS) | 0.4 | $2.6M | NEW | 75k | 34.67 |
|
| An2 Therapeutics (ANTX) | 0.4 | $2.6M | -19% | 530k | 4.84 |
|
| Serina Therapeutics Com Shs (SER) | 0.3 | $1.9M | 1.0M | 1.94 |
|
|
| Aligos Therapeutics Com New (ALGS) | 0.3 | $1.9M | 327k | 5.77 |
|
|
| Ibio Com New (IBIO) | 0.3 | $1.6M | 904k | 1.75 |
|
|
| Xilio Therapeutics (XLO) | 0.2 | $1.5M | 153k | 9.58 |
|
|
| CryoLife (AORT) | 0.2 | $1.1M | NEW | 49k | 22.47 |
|
| Bridgebio Oncology Therapeut Com New (BBOT) | 0.2 | $995k | 131k | 7.62 |
|
|
| Tela Bio (TELA) | 0.1 | $477k | 636k | 0.75 |
|
|
| Adagio Med Hldgs (ADGM) | 0.1 | $456k | -45% | 699k | 0.65 |
|
| NeuroOne Medical Technologies Corporat (NMTC) | 0.0 | $252k | NEW | 83k | 3.04 |
|
| Enveric Biosciences Com Shs (ENVB) | 0.0 | $248k | NEW | 180k | 1.38 |
|
| Modular Med Com New (MODD) | 0.0 | $118k | 26k | 4.50 |
|
|
| Qt Imaging Hldgs (QTI) | 0.0 | $62k | NEW | 15k | 4.07 |
|
| Rocket Pharmaceuticals *w Exp 09/02/202 (RCKTW) | 0.0 | $1.5k | 400k | 0.00 |
|
|
| Humacyte *w Exp 08/27/202 (HUMAW) | 0.0 | $474.981000 | 50k | 0.01 |
|
Past Filings by Sio Capital Management
SEC 13F filings are viewable for Sio Capital Management going back to 2010
- Sio Capital Management 2026 Q2 filed Aug. 14, 2026
- Sio Capital Management 2026 Q1 filed May 14, 2026
- Sio Capital Management 2025 Q4 filed Feb. 17, 2026
- Sio Capital Management 2025 Q3 filed Nov. 13, 2025
- Sio Capital Management 2025 Q2 filed Aug. 13, 2025
- Sio Capital Management 2025 Q1 filed May 15, 2025
- Sio Capital Management 2024 Q4 filed Feb. 14, 2025
- Sio Capital Management 2024 Q3 filed Nov. 14, 2024
- Sio Capital Management 2024 Q2 filed Aug. 14, 2024
- Sio Capital Management 2024 Q1 filed May 15, 2024
- Sio Capital Management 2023 Q3 filed Nov. 14, 2023
- Sio Capital Management 2023 Q2 filed Aug. 14, 2023
- Sio Capital Management 2023 Q1 filed May 12, 2023
- Sio Capital Management 2022 Q4 filed Feb. 13, 2023
- Sio Capital Management 2022 Q3 filed Nov. 14, 2022
- Sio Capital Management 2022 Q2 filed Aug. 15, 2022